Search | TVST | ARVO Journals

Showing 1 – 20 of 117

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2020

Deep learning-based automatic segmentation of intact ellipsoid zone area on optical coherence tomography images of USH2A-related retinal degeneration

Sina Farsiu; Jessica Loo; Jacque L Duncan; David G Birch; Glenn J Jaffe

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):485. doi:

ARVO Annual Meeting Abstract June 2020

Registry and Natural History Study to Evaluate Clinical Non-Central Geographic Atrophy (GA) Who are CarRIers of High-Risk GeneTic Variants Associated with Age-Related Macular Degeneration (CLARITY): Study Outline and Available Baseline Data

William Bridges; Nancy Holekamp; Stephen Couvillion; Raj Maturi; Jared S Nielsen; Dante Joseph Pieramici; Glenn J Jaffe; KD Nguyen; Renta Hutabarat; Stephen Eckert; Richard MacKenna; Kiran Patki; Alia Rashid; Johanna M Seddon; Sandra Rojas-Caro

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1043. doi:

ARVO Annual Meeting Abstract June 2020

Risuteganib Modifies Hydroquinone-regulated Gene Expression and Protects against Hydroquinone-induced Cytotoxic Effects in Human RPE Cells

Ping Yang; Zixuan Shao; Nicholas Besley; John Y Park; Hampar Karageozian; Vicken Karageozian; Glenn J Jaffe

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3117. doi:

ARVO Annual Meeting Abstract June 2020

Baseline visual fields in the RUSH2A study: Associated factors and correlation with measures of disease severity

Jacque L Duncan; Wendi Liang; Isabelle S Audo; David G Birch; Joseph Carroll; Janet K. Cheetham; Laura R Erker; Frederick L Ferris; Elise Heon; Robert Hufnagel; Alessandro Iannaccone; Glenn J Jaffe; Christine N Kay; Maureen Maguire; Michel Michaelides; Mark E Pennesi

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3364. doi:

ARVO Annual Meeting Abstract June 2020

Deep learning-based automatic segmentation of retinal cavitations on OCT images of MacTel2

Jessica Loo; Cindy Xinji Cai; Emily Chew; Martin Friedlander; Glenn J Jaffe; Sina Farsiu

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1616. doi:

ARVO Annual Meeting Abstract June 2020

Meta-learning approach to automatically register multivendor retinal images

Ali Hasan; Zengtian Deng; Jessica Loo; Dibyendu Mukherjee; Jacque L Duncan; David G Birch; Glenn J Jaffe; Sina Farsiu

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1634. doi:

ARVO Annual Meeting Abstract June 2020

In-vivo quantitative analysis of pterygium volume using anterior segment optical coherence tomography imaging

Sumru Onal; Jessica Loo; Victor L Perez Quinones; Tan Nguyen; Madhu Cherukury; Sina Farsiu; Glenn J Jaffe

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):488. doi:

ARVO Annual Meeting Abstract June 2020

Resveratrol Differentially Interacts with Oxidants to Protect against Oxidant-induced Stress in Human RPE cells

Nicholas Anthony Besley; Ping Yang; Glenn J Jaffe

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4160. doi:

ARVO Annual Meeting Abstract June 2020

Safety and Efficacy of Risuteganib in Intermediate Non-exudative Age-Related Macular Degeneration

Raj Maturi; Glenn J Jaffe; Justis P Ehlers; Peter K Kaiser; David S Boyer; Jeffrey S Heier; Julia A Kornfield; Baruch D Kuppermann; Hugo Quiroz-Mercado; Janine Aubel; Lisa Karageozian; Vicken H Karageozian; Melvin Sarayba

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1944. doi:

ARVO Annual Meeting Abstract June 2020

Development of IONIS-FB-L Rx to Treat Geographic Atrophy Associated with AMD

Glenn J Jaffe; Jayashree Sahni; Sascha Fauser; Richard S Geary; Eugene Schneider; Michael McCaleb

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4305. doi:

Retinal Cell Biology April 2020

Resveratrol Protects Against Hydroquinone-Induced Oxidative Threat in Retinal Pigment Epithelial Cells

PDF

Samantha E. Neal; Kristen L. Buehne; Nicholas A. Besley; Ping Yang; Peter Silinski; Jiyong Hong; Ian T. Ryde; Joel N. Meyer; Glenn J. Jaffe
TAGS: resveratrol, retinal pigment cell
Invest. Ophthalmol. Vis. Sci.. 2020; 61(4):32. doi: https://doi.org/10.1167/iovs.61.4.32

Includes: Supplemental Content

ARVO Annual Meeting Abstract July 2019

Automatic Deep Learning OCT Analysis Algorithm Reliably Reproduces Expert-Evaluated Outcome of a Randomized Clinical Trial for Macular Telangiectasia Type 2 Treatment

Jessica Loo; Traci E Clemons; Emily Y Chew; Martin Friedlander; Glenn J Jaffe; Sina Farsiu

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1449. doi:

ARVO Annual Meeting Abstract July 2019

Clinical outcomes following the triple procedure

Obi Umunakwe; Susan Wakil; Atalie C. Thompson; Glenn J Jaffe; Terry Kim; Leon Herndon

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6646. doi:

ARVO Annual Meeting Abstract July 2019

Luminate protects against hydroquinone–induced injury in human RPE cells

Ping Yang; Samantha Erin Neal; Glenn J Jaffe

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1944. doi:

ARVO Annual Meeting Abstract July 2019

Treatment of non-infectious uveitis that affects the posterior segment with a single intravitreal fluocinolone acetonide insert (FAi) – 3-year results. .

Glenn J Jaffe

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3858. doi:

ARVO Annual Meeting Abstract July 2019

Resveratrol protects against hydroquinone-induced damage in RPE cells

Samantha Erin Neal; Kristen Buehne; Peter Silinski; Ping Yang; Glenn Jaffe

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1942. doi:

New Developments in Vision Research April 2019

A Workshop on Measuring the Progression of Atrophy Secondary to Stargardt Disease in the ProgStar Studies: Findings and Lessons Learned

PDF

Ann-Margret Ervin; Rupert W. Strauss; Mohamed I. Ahmed; David Birch; Janet Cheetham; Frederick L. Ferris III; Michael S. Ip; Glenn J. Jaffe; Maureen G. Maguire; Etienne M. Schönbach; SriniVas R. Sadda; Sheila K. West; Hendrik P.N. Scholl; for the ProgStar Study Group
TAGS: atrophy, eye, spectral domain-optical coherence tomography, stargardt's disease, prospective studies
Trans. Vis. Sci. Tech.. 2019; 8(2):16. doi: https://doi.org/10.1167/tvst.8.2.16

ARVO Annual Meeting Abstract July 2018

Dissociations of the fluocinolone acetonide implant: experience from long-term follow-up during the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study

Elizabeth A Sugar; Janet A Holbrook; Alyce E Burke; Glenn J Jaffe; Albert T Vitale; Janet L. Davis; Douglas A Jabs

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):417. doi:

ARVO Annual Meeting Abstract July 2018

Long term Follow up of non-fibrotic scars in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT)

Ebenezer Daniel; Benjamin J Kim; Wei Pan; Juan E Grunwald; Gui-Shuang Ying; Cynthia A Toth; Glenn J Jaffe; Daniel F Martin; Maureen G. Maguire

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3252. doi:

ARVO Annual Meeting Abstract July 2018

Effect of Tec Kinases Inhibitor on Complement-mediated Release of Basic Fibroblast Growth Factor from Human RPE Cells

Ping Yang; Grace M Tewkesbury; Kristen L Buehne; Jae Yang; Peter Baciu; Glenn J Jaffe

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2461. doi:

1 2 3 4 5

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Deep learning-based automatic segmentation of intact ellipsoid zone area on optical coherence tomography images of USH2A-related retinal degeneration

Registry and Natural History Study to Evaluate Clinical Non-Central Geographic Atrophy (GA) Who are CarRIers of High-Risk GeneTic Variants Associated with Age-Related Macular Degeneration (CLARITY): Study Outline and Available Baseline Data

Risuteganib Modifies Hydroquinone-regulated Gene Expression and Protects against Hydroquinone-induced Cytotoxic Effects in Human RPE Cells

Baseline visual fields in the RUSH2A study: Associated factors and correlation with measures of disease severity

Deep learning-based automatic segmentation of retinal cavitations on OCT images of MacTel2

Meta-learning approach to automatically register multivendor retinal images

In-vivo quantitative analysis of pterygium volume using anterior segment optical coherence tomography imaging

Resveratrol Differentially Interacts with Oxidants to Protect against Oxidant-induced Stress in Human RPE cells

Safety and Efficacy of Risuteganib in Intermediate Non-exudative Age-Related Macular Degeneration

Development of IONIS-FB-L Rx to Treat Geographic Atrophy Associated with AMD

Resveratrol Protects Against Hydroquinone-Induced Oxidative Threat in Retinal Pigment Epithelial Cells

Automatic Deep Learning OCT Analysis Algorithm Reliably Reproduces Expert-Evaluated Outcome of a Randomized Clinical Trial for Macular Telangiectasia Type 2 Treatment

Clinical outcomes following the triple procedure

Luminate protects against hydroquinone–induced injury in human RPE cells

Treatment of non-infectious uveitis that affects the posterior segment with a single intravitreal fluocinolone acetonide insert (FAi) – 3-year results. .

Resveratrol protects against hydroquinone-induced damage in RPE cells

A Workshop on Measuring the Progression of Atrophy Secondary to Stargardt Disease in the ProgStar Studies: Findings and Lessons Learned

Dissociations of the fluocinolone acetonide implant: experience from long-term follow-up during the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study

Long term Follow up of non-fibrotic scars in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT)

Effect of Tec Kinases Inhibitor on Complement-mediated Release of Basic Fibroblast Growth Factor from Human RPE Cells

To View More...

You must be signed into an individual account to use this feature.